| USP订购编号 | 美国药典，USP分析标准品，英文名称，规格 | CAS编号查询 | UN编号对照 |
| USP-1098504 | Celecoxib (200 mg) | 169590-42-5 | |
| 2935904000 | |||
| USP-1098515 | Celecoxib Related Compound A (10 mg) (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170570-01-1 | |
| 2935909550 | |||
| USP-1098526 | Celecoxib Related Compound B (10 mg) (4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 331943-04-5 | |
| 2935909550 | |||
| USP-1098537 | Celecoxib Related Compound C (25 mg) (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) | 170570-09-9 | |
| 2933194350 | |||
| USP-1098570 | Celecoxib Related Compound D (25 mg) ((E)-4-{2-[1-(p-Tolyl)ethylidene]hydrazineyl}benzenesulfonamide) | 1061214-06-9 | |
| 2935909550 | |||
| USP-1099008 | Cephalexin (400 mg) | 23325-78-2 | |
| 2941906000 | |||
| USP-1099041 | Cephalexin Related Compound D (25 mg) (3-Hydroxy-4-methylthiophen-2(5H)-one) | 34876-35-2 | |
| 2934990005 | |||
| USP-1099063 | Cephalexin Related Compound F (25 mg) ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid) | 79750-46-2 | |
| 2934990005 | |||
| USP-1102408 | Cephapirin Benzathine (100 mg) | 97468-37-6 | |
| 2941906000 | |||
| USP-1102500 | Cephapirin Sodium (500 mg) | 24356-60-3 | |
| 2941906000 | |||
| USP-1102805 | Cephradine (300 mg) | 75975-70-1 | |
| 2941906000 | |||
| USP-1102929 | Cetirizine Hydrochloride (250 mg) | 83881-52-1 | |
| 2933595960 | |||
| USP-1102930 | Cetirizine Related Compound A (20 mg) ((RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate) | 246870-46-2 | |
| 2933599550 | |||
| USP-1102941 | Cetirizine Related Compound B (25 mg) (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride) | 108983-83-1 | |
| 2933599550 | |||
| USP-1102952 | Cetirizine Related Compound C (25 mg) (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) | 83881-37-2 | |
| 2933599550 | |||
| USP-1133638 | Chromium Picolinate (100 mg) | 14639-25-9 | |
| 2933399095 | |||
| USP-1133740 | Chrysanthemum Indicum Flower Dry Extract (500 mg) | N/A | |
| 1302190200 | |||
| USP-1133751 | Chrysanthemum X Morifolium Flower Dry Extract (500 mg) | N/A | |
| 1302190200 | |||
| USP-1133828 | Cimifugin (15 mg) | 37921-38-3 | |
| 2932996560 | |||
| USP-1133842 | L-Citrulline (200 mg) | 372-75-8 | |
| 2924190002 | |||
| USP-1133853 | Cidofovir (100 mg) | 149394-66-1 | |
| 2933599550 | |||
| USP-1133864 | Cidofovir Enantiomer (15 mg) (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine dihydrate) | N/A | |
| 2933599550 | |||
| USP-1133875 | Cidofovir Related Compound A (15 mg) (1-[(S)-3-Hydroxy-2-(O-ethylphosphonomethoxy)propyl]cytosine) | 1312776-50-3 | |
| 2933599550 | |||
| USP-1133886 | Cidofovir Related Compound B (15 mg) (1-[(S)-3-Hydroxy-2-(O,O-diethylphosphonomethoxy)propyl]cytosine hydrochloride) | N/A | |
| 2933599550 | |||
| USP-1133922 | Cinacalcet Related Compound C (50 mg) ((R)-N-[1-(Naphthalen-1-yl)ethyl]-3-[4-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | 1428118-39-1 | |
| 2921490002 | |||
| USP-1133933 | Cinnamic Acid (100 mg) | 140-10-3 | |
| 2916399000 | |||
| USP-1133966 | Cinacalcet Related Compound D (50 mg) ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride) | 1217809-88-5 | |
| 2921490002 | |||
| USP-1133977 | Cinacalcet Hydrochloride (250 mg) | 364782-34-3 | UN3077 |
| USP-1134007 | Chymotrypsin (300 mg) (需冷链运输) | 9004/7/3 | |
| 3507907000 | |||
| USP-1134018 | Ciclopirox (50 mg) | 29342-05-0 | UN3077 |
| USP-1134029 | Ciclopirox Related Compound A (25 mg) (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid) | N/A | |
| 2934990005 | |||
| USP-1134030 | Ciclopirox Olamine (125 mg) | 41621-49-2 | UN3077 |
| USP-1134040 | Ciclopirox Related Compound B (25 mg) (6-Cyclohexyl-4-methyl-2-pyrone) | 14818-35-0 | |
| 2932206000 | |||
| USP-1134051 | Cilastatin Ammonium Salt (100 mg) | 877674-82-3 | |
| 2930909265 | |||
| USP-1134062 | Cimetidine (200 mg) | 51481-61-9 | |
| 2933290000 | |||
| USP-1134073 | Cimetidine Hydrochloride (200 mg) | 70059-30-2 | |
| 2933290000 | |||
| USP-1727097 | Zolmitriptan Related Compound H (50 mg) (4,4-Diethoxy-N,N-dimethylbutan-1-amine) | 1116-77-4 | UN3267 |
| USP-1733119 | Meso-Zeaxanthin (5x 30 mg) (Beta-Beta-Carotene-3,3′-diol, (3R ,3′ S)-) | 31272-50-1 | |
| 3203000000 | |||
| USP-1A00290 | Isopropyl 4-acetylbenzoate (需冷链运输) (25 mg) (Isopropyl 4-acetylbenzoate) | 220089-22-5 | |
| 2918300000 | |||
| USP-1A00400 | Tetramethyl Ethylene Diamine (25 mg) (N1,N1,N2,N2-tetramethylethane-1,2-diamine) | 110-18-9 | UN2372 |
| USP-1A00900 | 4-Methylacetophenone (1-(4-Methylphenyl)-1-ethanone (4′-Methylacetophenone)) | 122-00-9 | |
| 2914399000 | |||
| USP-1A01310 | tert-Octylamine (25 mg) (2,4,4-trimethylpentan-2-amine) | 107-45-9 | UN2734 |
| USP-1A01350 | Bis(2-methylaminoethyl) Ether (25 mg) (2,2′-oxybis(N,N-dimethylethan-1-amine)) | 3033-62-3 | UN2922 |
| USP-1A01560 | Chlorothiophene Aldehyde (25 mg) (5-chlorothiophene-2-carbaldehyde) | 7283-96-7 | |
| 2934990005 | |||
| USP-1559505 | Prednisone Tablets (30 tablets) | 1953/3/2 | |
| 2937210000 | |||
| USP-1303750 | Hemoglobin Protease Substrate (100 g) (国际冷链运输要求) | 9008-02-0 | |
| 3002905250 | |||
| USP-1071304 | Bile Salts (10 g) | NA | |
| 3822190000 | |||
| USP-1133900 | Cinnamomum Cassia Twig Powder (5 g) | 84961-46-6 | |
| 1302190200 | |||
| USP-1234410 | Elemental Impurities Class 1 and 2A Mixture (120 mL) | N/A | UN1789 |
| USP-1234427 | Elemental Impurities Class 2B Mixture (120 mL) | N/A | UN1789 |
| USP-1234431 | Elemental Impurities Class 3 Mixture (120 mL) | N/A | UN2031 |
| USP-1356880 | Lanolin (20 g) | 8006-54-0 | |
| 1505009000 | |||
| USP-1356905 | Lanolin Alcohols (5 g) | 8027-33-6 | |
| 1505009000 | |||
| USP-1380502 | Memantine Hydrochloride (150 mg) | 41100-52-1 | |
| 2921300000 | |||
| USP-1443825 | Skim Milk Powder (20 g) | N/A | |
| 402210000 | |||
| USP-1443847 | Skim Milk Powder with Melamine – Level A (20 g) | N/A | |
| 402210000 | |||
| USP-1443872 | Skim Milk Powder with Melamine – Level C (20 g) | N/A | |
| 402210000 | |||
| USP-1443883 | Skim Milk Powder with Melamine – Level D (20 g) | N/A | |
| 402210000 | |||
| USP-1443894 | Skim Milk Powder with Melamine – Level E (20 g) | N/A | |
| 402210000 | |||
| USP-1500502 | Particle Count Set (2 blanks and 2 suspensions) | N/A | |
| 3903190000 | |||
| USP-1612652 | Simethicone (50 g) | 8050-81-5 | |
| 3910000000 | |||
| USP-1152825 | Cyclic Olefin Copolymer (3 strips, 2” x 2” x 1 mm each) | 26007-43-2 | |
| 3901905501 | |||
| USP-1277252 | Fluoride Dentifrice: Sodium Fluoride/Silica (4.6 oz) | N/A | |
| 3822190000 | |||
| USP-1277274 | Fluoride Dentifrice: Sodium Fluoride/Sodium Bicarbonate Powder (4 oz) | N/A | |
| 3822190000 | |||
| USP-1277354 | Fluoride Dentifrice: Sodium Monofluorophosphate/Dicalcium Phosphate (4.6 oz) | N/A | |
| 3822190000 | |||
| USP-1277423 | Fluoride Dentifrice: Sodium Monofluorophosphate (1500 ppm)/Silica (5.25 oz) | N/A | |
| 3822190000 | |||
| USP-1277456 | Fluoride Dentifrice: Stannous Fluoride-Silica (4 oz) | N/A | |
| 3822190000 | |||
| USP-1294839 | Gluten in Oat Flour Method Development Materials (7 x 50 g) | N/A | |
| 1104220000 | |||
| USP-1311306 | Homopolymer Polypropylene (3 Strips, 2” x 2 1/2” each) | 9003-07-0 | |
| 3920200000 | |||
| USP-1457844 | Near IR System Suitability (1 unit) (Dysprosium (Dy2O3), Erbium (Er2O3), Holmium (Ho2O3), talc [Mg3Si4O10(OH)2] (1:1:1:1 w/w)) | N/A | |
| 2846909000 | |||
| USP-1535813 | Scaffold Human Dermis Reference Photomicrographs (CD) | N/A | |
| 8523494000 | |||
| USP-1535824 | Bovine Acellular Dermal Matrix Reference Photomicrographs (CD) | N/A | |
| 8523494000 | |||
| USP-1535835 | Cultured Rat Pheochromocytoma Reference Photomicrographs (CD) | N/A | |
| 8523494000 | |||
| USP-1535846 | Graftskin Reference Photomicrographs (CD) | N/A | |
| 8523494000 | |||
| USP-1535857 | Human Fibroblast-Derived Skin Substitute Reference Photomicrographs (CD) | N/A | |
| 8523494000 | |||
| USP-1535868 | Cryopreserved Human Fibroblast-Derived Dermal Substitute Reference Photomicrographs (CD) | N/A | |
| 8523494000 | |||
| USP-1546183 | Polycarbonate (3 Strips, 2” x 2 1/2” each) | 25766-59-0 | |
| 3907400000 | |||
| USP-1546707 | High-Density Polyethylene (3 strips (2” x 2 1/2” each)) | 9002-88-4 | |
| 3920100000 | |||
| USP-1546809 | Low-Density Polyethylene (3 strips) | 9002-88-4 | |
| 3920100000 | |||
| USP-1546900 | Polyethylene Terephthalate (3 strips (2” x 2 1/2” each)) | 25038-59-9 | |
| 3921905050 | |||
| USP-1546922 | Polyethylene Terephthalate G (PETG) (3 Strips) | 25640-14-6 | |
| 3921905050 | |||
| USP-1613021 | Desiccant, Medium (2 pouches (approximate weight 80 grams, each)) | 1318-02-1 | |
| 3824999370 | |||
| USP-1067001 | Betamethasone Acetate (500 mg) | 987-24-6 | UN2811 |
| USP-1067034 | Betamethasone Acetate Related Compound C (20 mg) (9-Fluoro-11Beta,17,21-trihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 11,21-diacetate) | 330157-05-6 | |
| 2918992090 | |||
| USP-1067045 | Betamethasone Acetate Related Compound D (20 mg) (9,11Beta-Epoxy-17,21-dihydroxy-16Beta-methylpregna-1,4-diene-3,20-dione 21-acetate) | 912-38-9 | |
| 2915399500 | |||
| USP-1067307 | Betamethasone Benzoate (200 mg) | 22298-29-9 | UN2811 |
| USP-1067704 | Betamethasone Dipropionate (125 mg) | 5593-20-4 | |
| 2937220000 | |||
| USP-1067726 | Betamethasone Dipropionate Related Compound B (25 mg) (9-Fluoro-11Beta,21-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17-yl propionate) | 5534-13-4 | |
| 2937220000 | |||
| USP-1067737 | Betamethasone Dipropionate Related Compound C (25 mg) (9-Fluoro-11Beta,17-dihydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate) | 75883-07-7 | |
| 2937220000 | |||
| USP-1067760 | Betamethasone Dipropionate Related Compound F (30 mg) (9,11Beta-Epoxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) | 66917-44-0 | |
| 2918992090 | |||
| USP-1067781 | Betamethasone Dipropionate Related Compound H (30 mg) (6alpha-Bromo-9-fluoro-11Beta-hydroxy-16Beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate) | 1186048-34-9 | |
| 2918992090 | |||
| USP-1068004 | Betamethasone Sodium Phosphate (500 mg) | 151-73-5 | UN2811 |
| USP-1069007 | Betamethasone Valerate (200 mg) | 2152-44-5 | |
| 2937220000 | |||
| USP-1069018 | Betamethasone Valerate Related Compound A (50 mg) (9-Fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-21-yl valerate) | 2240-28-0 | |
| 2937220000 | |||
| USP-1069095 | Betamethasone Valerate System Suitability Mixture (15 mg) (A mixture containing betamethasone valerate and betamethasone valerate related compound H) | NA | |
| 3822190000 | |||
| USP-1069903 | Betaxolol Hydrochloride (200 mg) | 63659-19-8 | |
| 2922190900 | |||
| USP-1069914 | Betaxolol Related Compound A (20 mg) (1-(4-Ethylphenoxy)-3-(isopropylamino)propan-2-ol) | 67193-95-7 | |
| 2922199695 | |||
| USP-1071009 | Bethanechol Chloride (200 mg) | 590-63-6 | |
| 2924190002 | |||
| USP-1071202 | Bicalutamide (200 mg) | 90357-06-5 | UN3077 |
| USP-1071213 | Bicalutamide Related Compound A (25 mg) (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide) | N/A | |
| 2930902000 | |||
| USP-1071224 | Bicalutamide Related Compound B (10 mg) ((RS)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-(3-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide) | 1166228-30-3 | UN3077 |
| USP-1071268 | Powdered Bilberry Extract (500 mg) | 84082-34-8 | |
| 1302190200 | |||
| USP-1071381 | Biochanin A (20 mg) | 491-80-5 | |
| 2932992100 | |||
| USP-1071508 | Biotin (200 mg) | 58-85-5 | |
| 2936299055 | |||
| USP-1073423 | Biphenyl (500 mg) | 92-52-4 | UN3077 |
| USP-1074007 | Bisacodyl (125 mg) | 603-50-9 | |
| 2933399095 | |||
| USP-1074030 | Bisacodyl Related Compound A (20 mg) (4,4′-(Pyridin-2-ylmethylene)diphenol) | 603-41-8 | |
| 2933399095 | |||
| USP-1074042 | Bisacodyl Related Compound B (20 mg) (2,4′-(Pyridin-2-ylmethylene)diphenol) | 16985-05-0 | |
| 2933399095 | |||
| USP-1074051 | Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | 72901-16-7 | |
| 2933399095 | |||
| USP-1074073 | Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) | 111664-35-8 | |
| 2933399095 | |||
| USP-1075305 | Bisdesmethoxycurcumin (30 mg) | 33171-05-0 | |
| 2914500000 | |||
| USP-1075531 | Bismuth Citrate (100 mg) | 813-93-4 | |
| 2918150000 | |||
| USP-1075553 | Bismuth Subsalicylate (100 mg) | 14882-18-9 | |
| 2918215100 | |||
| USP-1075600 | Bismuth Subcarbonate (1 g) (AS) | 5892/10/4 | |
| 2836992000 | |||
| USP-1075677 | Bisoctrizole (200 mg) | 103597-45-1 | |
| 2933997500 | |||
| USP-1075688 | Bisoctrizole Related Compound A (25 mg) (2-(2H-Benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl) phenol) | 3147-75-9 | |
| 2933997500 | |||
| USP-1075699 | Bisoctrizole Resolution Mixture (50 mg) | N/A | |
| 2933997500 | |||
| USP-1075757 | Bisoprolol Fumarate (200 mg) | 104344-23-2 | |
| 2922190900 | |||
| USP-1075768 | Bisoprolol Related Compound A (50 mg) (1-[4-(Hydroxymethyl)phenoxy]-3-(isopropylamino)propan-2-ol) | 62572-93-4 | |
| 2922199695 | |||
| USP-1075780 | Bisoprolol Related Compound C (50 mg) (1-(Isopropylamino)-3-(4-methylphenoxy)propan-2-ol) | 5790-46-5 | |
| 2922199695 | |||
| USP-1075799 | Bisoprolol Related Compound D (50 mg) (1-(4-{[(2-Isopropoxyethoxy)methoxy]methyl}phenoxy)-3-(isopropylamino)propan-2-ol fumarate (2:1) salt) | N/A | |
| 2922199695 | |||
| USP-1075815 | Bisoprolol Related Compound F (50 mg) (2-Isopropoxyethyl 4-[2-hydroxy-3-(isopropylamino)propoxy]benzoate) | 864544-37-6 | |
| 2922504500 | |||
| USP-1075870 | Bitter Orange Fruit Flavonoids Dry Extract (1 g) | N/A | |
| 2106906798 | |||
| USP-1075892 | Bisphenol A (200 mg) | 1980/5/7 | UN3077 |
| USP-1076115 | Bosentan (200 mg) | 157212-55-0 | |
| 2935909550 | |||
| USP-1076126 | Bosentan Related Compound A (15 mg) (4-(tert-butyl)-N-[6-chloro-5-(2-methoxyphenoxy)-(2,2′-bipyrimidin)-4-yl] benzenesulfonamide) | 150727-06-3 | |
| 2935909550 | |||
| USP-1076137 | Bosentan Related Compound B (15 mg) (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2′-bipyrimidin)-4-yl]benzenesulfonamide) | 174227-14-6 | |
| 2935909550 | |||
| USP-1374226 | Magnesium Carbonate (2 g) | 23389-33-5 | |
| 2836999050 | |||
| USP-1374248 | Magnesium Chloride (1 g) | 7791-18-6 | |
| 2827310000 | |||
| USP-1374259 | Magnesium Citrate (500 mg) | 3344-18-1 | |
| 2918150000 | |||
| USP-1379140 | Meglumine (500 mg) | 6284-40-8 | |
| 2922199695 | |||
| USP-1379172 | Megestrol Acetate Related Compound H (20 mg) | 907193-65-1 | |
| 2915399500 | |||
| USP-1379183 | Melamine (250 mg) (2,4,6-Triamino-1,3,5-triazine) | 108-78-1 | |
| 2933610000 | |||
| USP-1379265 | Melengestrol Acetate Related Compound A (25 mg) (16-Methylene-3,20-dioxopregn-4-en-17-yl acetate) | 6815-51-6 | |
| 2937230000 | |||
| USP-1379276 | Melengestrol Acetate Related Compound B (25 mg) (6,16-Dimethylene-3,20-dioxopregn-4-en-17-yl acetate) | 80097-73-0 | |
| 2937230000 | |||
| USP-1379300 | Melphalan Hydrochloride (200 mg) | 1465-26-5 | UN2811 |
| USP-1379401 | Meloxicam (400 mg) | 71125-38-7 | UN2811 |
| USP-1379412 | Meloxicam Related Compound A (25 mg) (ethyl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate- 1,1-dioxide) | 24683-26-9 | |
| 2934990005 | |||
| USP-1379423 | Meloxicam Related Compound B (25 mg) (5-Methylthiazol-2-amine) | 7305-71-7 | UN3077 |
| USP-1379434 | Meloxicam Related Compound C (30 mg) (Isopropyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate-1,1-dioxide) | N/A | |
| 2934990005 | |||
| USP-1379445 | 4-Methoxymeloxicam (30 mg) (4-methoxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide) | 1391051-96-9 | |
| 2934100000 | |||
| USP-1379456 | (Z)-N’-Methylmeloxicam (30 mg) ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide) | 1145656-36-5 | |
| 2934990005 | |||
| USP-1379605 | Mefenamic Acid (200 mg) | 61-68-7 | |
| 2922492050 | |||
| USP-1380105 | Melatonin (150 mg) | 73-31-4 | |
| 2937909000 | |||
| USP-1380116 | Melatonin Related Compound A (15 mg) (2-(5-methoxy-1H-indol-3-yl)ethanamine) | 608-07-1 | |
| 2933998350 | |||
| USP-1380524 | Memantine Related Compound B (15 mg) (3,5-Dimethyladamantane-1-ol) | 707-37-9 | |
| 2906195000 | |||
| USP-1380557 | Memantine Related Compound E (15 mg) (N-3,5-Dimethyladamantan-1-yl formamide) | 351329-88-9 | |
| 2924299500 | |||
| USP-1380568 | Memantine Related Compound F (50 mg) (3-Amino-5,7-dimethyladamantan-1-ol hydrochloride) | 356572-08-2 | |
| 2922199695 |